NCT02748915

Brief Summary

The primary objective of this research is to evaluate the relationships between multiple data from cochlear implant (CI) adult users to and to estimate predictive models of their fitting parameters. In a group of patients, the Electrically-evoked Compound Action Potentials (ECAP) will be collected intra-operatively and the correlation with demographic data (deafness duration, age deafness onset, etiology, duration of cochlear implant use of CI), auditory performances and subjective measures used for implant fitting (hearing threshold and most comfortable level) will be calculated. In a second group of experienced users (more than 9months of use of their CI), ECAP and Electrically-evoked Auditory Brainstem Response (EABR) will be collected after 9 months of CI experience and after 12 months or more of use. Correlation analyzes with demographic data, performance and fitting parameters will be performed as well. Statistical predictive models for both fitting at the activation or in experienced users should be developed according to the correlation analysis. The secondary objective is to evaluate the effects of simultaneous stimulation on hearing performances. Simultaneous stimulations will be delivered in one ear (bimodal condition) in patients using an Electro-Acoustic Stimulation device (EAS) or in the two ears (binaural condition) for bilateral CI users. ECAP, EABR and speech perception will be measured and compared in the different conditions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
49

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 26, 2016

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 14, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 22, 2016

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 4, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 4, 2020

Completed
Last Updated

December 19, 2025

Status Verified

December 1, 2025

Enrollment Period

4.4 years

First QC Date

April 14, 2016

Last Update Submit

December 13, 2025

Conditions

Keywords

Cochlear ImplantECAPEABRperceptual levelshearing performances

Outcome Measures

Primary Outcomes (1)

  • ECAP threshold

    ECAP amplitude growth function (AGF) will be recorded on three cochlear sites (basal, medial, apical) in all patients using their implants for more than 11 months. ECAP thresholds (in current unit) will be determined, compared according to the stimulation sites and correlation tests with the other measures will be performed. These records could also be compared to ECAP AGF recorded in clinical routine/during control visit before these 11 months that includes intra-operative records when available. The ECAP threshold recorded with and without acoustic stimulations will be compared in patients using EAS devices.

    from 11 months after cochlear implant activation

Secondary Outcomes (20)

  • ECAP threshold

    9 months after cochlear implant activation

  • ECAP maximal amplitude

    from 11 months after cochlear implant activation

  • ECAP maximal amplitude

    9 months after cochlear implant activation

  • ECAP latency

    from 11 months after cochlear implant activation

  • ECAP latency

    9 months after cochlear implant activation

  • +15 more secondary outcomes

Study Arms (3)

Patients using cochlear implants

EXPERIMENTAL

All patients using cochlear implants included in the study will take electrophysiological and psychoacoustic tests to measure auditive parameters regarding the study objectives : ECAP, EABR, speech recognition and MCL.

Other: Electrophysiological and psychoacoustic tests

Patients using EAS device

EXPERIMENTAL

Patients using EAS device for more than 11 months will take electrophysiological and psychoacoustic tests with the implant functioning only with electrical pulses or in bimodal mode to measure ECAP, EABR, speech recognition and MCL ; this will allow to perform bimodal comparison.

Other: Electrophysiological and psychoacoustic tests

Patients with bilateral cochlear implant

EXPERIMENTAL

Patients with bilateral cochlear implant for more than 11 months will take electrophysiological and psychoacoustic tests to measure ECAP, EABR, speech recognition, and MCL. The binaural interaction component will also be measured ; this will allow to perform binaural comparison.

Other: Electrophysiological and psychoacoustic tests

Interventions

Patients using EAS devicePatients using cochlear implantsPatients with bilateral cochlear implant

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Good general health status including no neuropsychological diseases affecting intellectual capacities
  • Users of cochlear implant or electro-acoustic stimulation devices
  • Normal otoscopy
  • No excessive sound exposure within 48h before the measure

You may not qualify if:

  • For women, possibility of pregnancy (absence of effective contraception or confirmed menopause);
  • Concomitant use of ototoxic or psychotropic treatment with anxiolytic and / or antipsychotic

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Edouard Herriot - Service ORL Pavillon U

Lyon, 69437, France

Location

Related Publications (2)

  • Joly CA, Reynard P, Hermann R, Seldran F, Gallego S, Idriss S, Thai-Van H. Intra-Cochlear Current Spread Correlates with Speech Perception in Experienced Adult Cochlear Implant Users. J Clin Med. 2021 Dec 13;10(24):5819. doi: 10.3390/jcm10245819.

  • Joly CA, Pean V, Hermann R, Seldran F, Thai-Van H, Truy E. Using Electrically-evoked Compound Action Potentials to Estimate Perceptive Levels in Experienced Adult Cochlear Implant Users. Otol Neurotol. 2017 Oct;38(9):1278-1289. doi: 10.1097/MAO.0000000000001548.

Study Officials

  • Eric TRUY, Professor

    Hospices Civils de Lyon

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 14, 2016

First Posted

April 22, 2016

Study Start

January 26, 2016

Primary Completion

June 4, 2020

Study Completion

June 4, 2020

Last Updated

December 19, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations